US Policy Momentum, Clinical Progress Fueling Psychedelics Market in 2025
When the US Food and Drug Administration (FDA) rejected Lykos Therapeutics’ new drug application for MDMA-assisted therapy last August, the...
When the US Food and Drug Administration (FDA) rejected Lykos Therapeutics’ new drug application for MDMA-assisted therapy last August, the...
In this video, Joe shares how to trade MACD signals using multiple timeframes, and how to spot stock market pullback...
The stock market’s action on Wednesday was a bit like trying to pick a dinner spot with friends—lots of back...
Here’s a quick recap of the crypto landscape for Wednesday (May 7) as of 9:00 p.m. UTC. Get the latest...
Saga Metals Corp. (‘SAGA’ or the ‘Company’) (TSXV: SAGA) (OTCQB: SAGMF) (FSE: 20H) a North American exploration company specializing in...
In this video, Dave reveals four key charts he’s watching to determine whether the S&P 500 and Nasdaq 100 will...
Trump’s latest Hollywood “hit” isn’t the kind you stream. Threatening to slap a 100% tariff on films produced in foreign...
The global pharmaceutical market reached a total value of US$1.38 trillion in 2024, according to Research and Markets, up significantly...
Copper prices are being pushed skyward as China’s stockpiles sit on the verge of depletion and as US demand for...
Communication Services Drops to #5 The composition of the top five sectors remains largely stable this week, with only slight...
Copyright © 2025 InvestDailyPro. All Rights Reserved.
Disclaimer: InvestDailyPro.com, its managers, its employees, and assigns (collectively InvestDailyPro ) do not make any guarantee or warranty about what is advertised above. Information provided by this website is for research purposes only and should not be considered as personalized financial advice.
The Company is not affiliated with, nor does it receive compensation from, any specific security. The Company is not registered or licensed by any governing body in any jurisdiction to give investing advice or provide investment recommendation. Any investments recommended here should be taken into consideration only after consulting with your investment advisor and after reviewing the prospectus or financial statements of the company.